Drug General Information
Drug ID
D0R0ZC
Former ID
DNC009328
Drug Name
KNI-10539
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529771]
Structure
Download
2D MOL

3D MOL

Formula
C39H50N4O6S
Canonical SMILES
CCCCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3C<br />SC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C
InChI
1S/C39H50N4O6S/c1-6-7-17-40-28-18-24(2)35(25(3)19-28)49-22-32(45)41-30(20-26-13-9-8-10-14-26)34(46)38(48)43-23-50-39(4,5)36(43)37(47)42-33-29-16-12-11-15-27(29)21-31(33)44/h8-16,18-19,30-31,33-34,36,40,44,46H,6-7,17,20-23H2,1-5H3,(H,41,45)(H,42,47)/t30-,31+,33-,34-,36+/m0/s1
InChIKey
YFOGAJAJKAWILS-SQKWSBCUSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [529771]
References
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Ref 529771Bioorg Med Chem. 2008 Dec 1;16(23):10049-60. Epub 2008 Oct 10.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.